Associations between sleep disturbances and diabetes mellitus among blacks with metabolic syndrome: Results from the Metabolic Syndrome Outcome Study (MetSO)

Alberto Ramos, Douglas Wallace, Seithikurippu Ratnas Pandi-Perumal, Natasha J. Williams, Chimene Castor, Mary Ann Sevick, Samy I. McFarlane, Girardin Jean-Louis

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction. The association between sleep disturbances and cardiometabolic diseases has been understudied in blacks with metabolic syndrome. Methods. This study is a cross-sectional analysis of the Metabolic Syndrome Outcome Study (MetSO) trial. We assessed insomnia symptoms, sleep duration, and risk for sleep apnea. Multivariate logistic regression models evaluated the association between sleep disturbances with diabetes mellitus (DM) and the combined outcomes of DM and hypertension as well as DM and dyslipidemia. Results. The sample consisted of 1,013 participants, mean age of 62 ± 14 years and 61% female. DM was diagnosed in 60% of the sample. Sleep apnea risk was observed in 48% of the sample, while 10% had insomnia symptoms and 65% reported short sleep duration (< 6 hours). Sleep apnea risk, but not insomnia or sleep duration, was associated with DM (OR 1.66; 95% CI 1.21-2.28), adjusting for age, sex, income, obesity (BMI ≥ 30 kg/m<sup>2</sup>), tobacco use, alcohol use, hypertension, dyslipidemia, and depression. In fully adjusted models, sleep apnea risk was associated with the combined outcome of DM-hypertension (OR 1.95; 95% CI 1.42-2.69), but not with diabetes-dyslipidemia. Conclusion. We observed a strong association between sleep apnea risk and diabetes mellitus among blacks with metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)233-237
Number of pages5
JournalAnnals of Medicine
Volume47
Issue number3
DOIs
StatePublished - May 1 2015

Fingerprint

Diabetes Mellitus
Sleep
Sleep Apnea Syndromes
Outcome Assessment (Health Care)
Dyslipidemias
Sleep Initiation and Maintenance Disorders
Hypertension
Logistic Models
Tobacco Use
Cross-Sectional Studies
Alcohols
Depression

Keywords

  • Black race/ethnicity
  • Diabetes mellitus
  • Metabolic syndrome
  • Sleep apnea

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Associations between sleep disturbances and diabetes mellitus among blacks with metabolic syndrome : Results from the Metabolic Syndrome Outcome Study (MetSO). / Ramos, Alberto; Wallace, Douglas; Pandi-Perumal, Seithikurippu Ratnas; Williams, Natasha J.; Castor, Chimene; Sevick, Mary Ann; McFarlane, Samy I.; Jean-Louis, Girardin.

In: Annals of Medicine, Vol. 47, No. 3, 01.05.2015, p. 233-237.

Research output: Contribution to journalArticle

Ramos, Alberto ; Wallace, Douglas ; Pandi-Perumal, Seithikurippu Ratnas ; Williams, Natasha J. ; Castor, Chimene ; Sevick, Mary Ann ; McFarlane, Samy I. ; Jean-Louis, Girardin. / Associations between sleep disturbances and diabetes mellitus among blacks with metabolic syndrome : Results from the Metabolic Syndrome Outcome Study (MetSO). In: Annals of Medicine. 2015 ; Vol. 47, No. 3. pp. 233-237.
@article{98ffead0e80d4f4b82fb3ce47a79c02b,
title = "Associations between sleep disturbances and diabetes mellitus among blacks with metabolic syndrome: Results from the Metabolic Syndrome Outcome Study (MetSO)",
abstract = "Introduction. The association between sleep disturbances and cardiometabolic diseases has been understudied in blacks with metabolic syndrome. Methods. This study is a cross-sectional analysis of the Metabolic Syndrome Outcome Study (MetSO) trial. We assessed insomnia symptoms, sleep duration, and risk for sleep apnea. Multivariate logistic regression models evaluated the association between sleep disturbances with diabetes mellitus (DM) and the combined outcomes of DM and hypertension as well as DM and dyslipidemia. Results. The sample consisted of 1,013 participants, mean age of 62 ± 14 years and 61{\%} female. DM was diagnosed in 60{\%} of the sample. Sleep apnea risk was observed in 48{\%} of the sample, while 10{\%} had insomnia symptoms and 65{\%} reported short sleep duration (< 6 hours). Sleep apnea risk, but not insomnia or sleep duration, was associated with DM (OR 1.66; 95{\%} CI 1.21-2.28), adjusting for age, sex, income, obesity (BMI ≥ 30 kg/m2), tobacco use, alcohol use, hypertension, dyslipidemia, and depression. In fully adjusted models, sleep apnea risk was associated with the combined outcome of DM-hypertension (OR 1.95; 95{\%} CI 1.42-2.69), but not with diabetes-dyslipidemia. Conclusion. We observed a strong association between sleep apnea risk and diabetes mellitus among blacks with metabolic syndrome.",
keywords = "Black race/ethnicity, Diabetes mellitus, Metabolic syndrome, Sleep apnea",
author = "Alberto Ramos and Douglas Wallace and Pandi-Perumal, {Seithikurippu Ratnas} and Williams, {Natasha J.} and Chimene Castor and Sevick, {Mary Ann} and McFarlane, {Samy I.} and Girardin Jean-Louis",
year = "2015",
month = "5",
day = "1",
doi = "10.3109/07853890.2015.1015601",
language = "English (US)",
volume = "47",
pages = "233--237",
journal = "Annals of Medicine",
issn = "0785-3890",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Associations between sleep disturbances and diabetes mellitus among blacks with metabolic syndrome

T2 - Results from the Metabolic Syndrome Outcome Study (MetSO)

AU - Ramos, Alberto

AU - Wallace, Douglas

AU - Pandi-Perumal, Seithikurippu Ratnas

AU - Williams, Natasha J.

AU - Castor, Chimene

AU - Sevick, Mary Ann

AU - McFarlane, Samy I.

AU - Jean-Louis, Girardin

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Introduction. The association between sleep disturbances and cardiometabolic diseases has been understudied in blacks with metabolic syndrome. Methods. This study is a cross-sectional analysis of the Metabolic Syndrome Outcome Study (MetSO) trial. We assessed insomnia symptoms, sleep duration, and risk for sleep apnea. Multivariate logistic regression models evaluated the association between sleep disturbances with diabetes mellitus (DM) and the combined outcomes of DM and hypertension as well as DM and dyslipidemia. Results. The sample consisted of 1,013 participants, mean age of 62 ± 14 years and 61% female. DM was diagnosed in 60% of the sample. Sleep apnea risk was observed in 48% of the sample, while 10% had insomnia symptoms and 65% reported short sleep duration (< 6 hours). Sleep apnea risk, but not insomnia or sleep duration, was associated with DM (OR 1.66; 95% CI 1.21-2.28), adjusting for age, sex, income, obesity (BMI ≥ 30 kg/m2), tobacco use, alcohol use, hypertension, dyslipidemia, and depression. In fully adjusted models, sleep apnea risk was associated with the combined outcome of DM-hypertension (OR 1.95; 95% CI 1.42-2.69), but not with diabetes-dyslipidemia. Conclusion. We observed a strong association between sleep apnea risk and diabetes mellitus among blacks with metabolic syndrome.

AB - Introduction. The association between sleep disturbances and cardiometabolic diseases has been understudied in blacks with metabolic syndrome. Methods. This study is a cross-sectional analysis of the Metabolic Syndrome Outcome Study (MetSO) trial. We assessed insomnia symptoms, sleep duration, and risk for sleep apnea. Multivariate logistic regression models evaluated the association between sleep disturbances with diabetes mellitus (DM) and the combined outcomes of DM and hypertension as well as DM and dyslipidemia. Results. The sample consisted of 1,013 participants, mean age of 62 ± 14 years and 61% female. DM was diagnosed in 60% of the sample. Sleep apnea risk was observed in 48% of the sample, while 10% had insomnia symptoms and 65% reported short sleep duration (< 6 hours). Sleep apnea risk, but not insomnia or sleep duration, was associated with DM (OR 1.66; 95% CI 1.21-2.28), adjusting for age, sex, income, obesity (BMI ≥ 30 kg/m2), tobacco use, alcohol use, hypertension, dyslipidemia, and depression. In fully adjusted models, sleep apnea risk was associated with the combined outcome of DM-hypertension (OR 1.95; 95% CI 1.42-2.69), but not with diabetes-dyslipidemia. Conclusion. We observed a strong association between sleep apnea risk and diabetes mellitus among blacks with metabolic syndrome.

KW - Black race/ethnicity

KW - Diabetes mellitus

KW - Metabolic syndrome

KW - Sleep apnea

UR - http://www.scopus.com/inward/record.url?scp=84930371532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930371532&partnerID=8YFLogxK

U2 - 10.3109/07853890.2015.1015601

DO - 10.3109/07853890.2015.1015601

M3 - Article

C2 - 25856540

AN - SCOPUS:84930371532

VL - 47

SP - 233

EP - 237

JO - Annals of Medicine

JF - Annals of Medicine

SN - 0785-3890

IS - 3

ER -